NL1014634C1 - Zolpidemzouten. - Google Patents

Zolpidemzouten. Download PDF

Info

Publication number
NL1014634C1
NL1014634C1 NL1014634A NL1014634A NL1014634C1 NL 1014634 C1 NL1014634 C1 NL 1014634C1 NL 1014634 A NL1014634 A NL 1014634A NL 1014634 A NL1014634 A NL 1014634A NL 1014634 C1 NL1014634 C1 NL 1014634C1
Authority
NL
Netherlands
Prior art keywords
zolpidem
salt
tartrate
hydrogen
crystalline
Prior art date
Application number
NL1014634A
Other languages
English (en)
Dutch (nl)
Inventor
Jacobus Maria Lemmens
Frantisek Picha
Theodorus Hendricus Ant Peters
Gerrit Jan Bouke Ettema
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99203478A external-priority patent/EP1038875B1/en
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of NL1014634C1 publication Critical patent/NL1014634C1/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL1014634A 1999-03-25 2000-03-13 Zolpidemzouten. NL1014634C1 (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US12649499P 1999-03-25 1999-03-25
US12649499 1999-03-25
EP99203478 1999-10-22
EP99203478A EP1038875B1 (en) 1999-03-25 1999-10-22 Imidazopyridine derivatives and process for making them
US44997499 1999-11-26
US09/449,974 US6242460B1 (en) 1999-03-25 1999-11-26 Zolpidem salt forms

Publications (1)

Publication Number Publication Date
NL1014634C1 true NL1014634C1 (nl) 2000-08-03

Family

ID=27240136

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1014634A NL1014634C1 (nl) 1999-03-25 2000-03-13 Zolpidemzouten.

Country Status (9)

Country Link
EP (1) EP1163241B1 (pt)
AT (1) ATE297924T1 (pt)
AU (1) AU3464200A (pt)
DE (1) DE60020814T2 (pt)
DK (1) DK1163241T3 (pt)
ES (1) ES2240074T3 (pt)
NL (1) NL1014634C1 (pt)
PT (1) PT1163241E (pt)
WO (1) WO2000058310A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2248154T3 (es) * 1999-11-22 2006-03-16 Egis Gyogyszergyar Rt. Procedimiento para la preparacion de 6-metil-2-(4-metil-fenil)-imidazo(1,2-a)-piridina-3-(n,n-dimetil-acetamida) y productos intermedios.
PT1473036E (pt) * 2000-04-24 2006-10-31 Teva Pharma Solvato de hemitartarato de zolpidem
EP1604663A1 (en) * 2000-04-24 2005-12-14 Teva Pharmaceutical Industries Ltd Zolpidem Hemitartrate Form H Solvate
WO2006008636A2 (en) * 2004-07-16 2006-01-26 Ranbaxy Laboratories Limited Processes for the preparation of zolpidem and its hemitartrate
EP1948655A1 (en) * 2005-10-03 2008-07-30 Mallinckrodt, Inc. Process for preparing zolpidem hemitartrate and tartrate polymorphs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires

Also Published As

Publication number Publication date
EP1163241B1 (en) 2005-06-15
PT1163241E (pt) 2005-08-31
DE60020814T2 (de) 2006-05-04
DK1163241T3 (da) 2005-10-10
ES2240074T3 (es) 2005-10-16
WO2000058310A1 (en) 2000-10-05
DE60020814D1 (de) 2005-07-21
EP1163241A1 (en) 2001-12-19
AU3464200A (en) 2000-10-16
ATE297924T1 (de) 2005-07-15

Similar Documents

Publication Publication Date Title
JP6946194B2 (ja) キナーゼを調節する化合物の固体形態
US6242460B1 (en) Zolpidem salt forms
KR101918678B1 (ko) Ｒ)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형
KR100266499B1 (ko) 나프티리딘 카복실산 유도체의 염 및 그의 수화물
TW202334115A (zh) N-(4-(4-(環丙基甲基)哌嗪-1-羰基)苯基)喹啉-8-磺醯胺之結晶型
TW200944508A (en) Novel solid forms of bendamustine hydrochloride
US20090247532A1 (en) Crystalline polymorph of sitagliptin phosphate and its preparation
ES2691971T3 (es) Composiciones farmacéuticas que comprenden rifaximina y aminoácidos, procedimiento de preparación y sus usos
TW200838536A (en) Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
JP2003530321A (ja) Ｎ−［４−［２−（２−アミノ−４，７−ジヒドロ−４−オキソ−３Ｈ−ピロロ［２，３−ｄ］ピリミジン−５−イル）エチル］ベンゾイル］−Ｌ−グルタミン酸の新規結晶形およびその製造方法
IL100091A (en) Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
EP1939176A1 (en) Salts of Tegaserod
EP3613733B1 (en) Novel crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1h-pyrazol-5-ol hydrochloride
TW201514165A (zh) Ｄ-葡萄糖醇，１-脫氧-１-（甲胺基）-，-１-（６-胺基-３，５-二氟吡啶-２-基）-８-氯-６-氟-１，４-二氫-７-（３-羥基氮雜環丁烷-１-基）-４-側氧基-３-喹啉羧酸的結晶形態與其製備程序
MX2012000749A (es) Bencensulfonato de 2-[[[2-[(hidroxiacetil) amino]-4-piridinil]meti l] tio]-n-[4-(trifluorometox)fenil]-3-piridincarboxamida, cristal del mismo, cristal polimorfo de este y metodos para la produccion de estos.
TWI815820B (zh) ２－（５－（４－（２－嗎啉乙氧基）苯基）吡啶－２－基）－ｎ－芐乙醯胺之固態形式
NL1014634C1 (nl) Zolpidemzouten.
CN115385893A (zh) 与吡啶酰基哌啶5-ht1f激动剂相关的组合物和方法
CA2579119C (en) Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
JPH11513402A (ja) モルヒネ−６−グルクロニドの新しい結晶形態
US20160136148A1 (en) Solid dispersions of amorphous paroxetine mesylate
JP6656505B2 (ja) オービットアジン−フマル酸塩、水和物、結晶形及びその調製方法
US20080064727A1 (en) Crystalline forms of tiagabine hydrochloride
US8258155B2 (en) Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof
MXPA02008376A (es) Material cristalino.

Legal Events

Date Code Title Description
VD2 Discontinued due to expiration of the term of protection

Effective date: 20060313